Close Menu

University of Tokyo

The Tokyo-based firm is looking to expand into the US market following a recent ¥700 million ($6.6 million) Series B financing round.

he single-cell microbiome sequencing firm has raised a total of ¥1.5 billion in equity financing since its founding in 2018.

The GWAS of more than 200,000 Japanese individuals across 42 diseases identified 25 novel loci shared between Japanese and European populations.

In Science this week: mass spectrometric analysis of the SARS-CoV-2 spike protein, and more.

Alcohol use in combination with ALDH2 mutations or germline changes in the CDH1 gene corresponded to a subset of diffuse-type gastric cancer cases in East Asian individuals.

In PLOS this week: genomic epidemiological features of dengue virus in Guangdong, analysis of ancient plaque give insight into past diets, and more.

By participating in the project, the company, located in Tokyo, hopes to improve its cloud-based data management services while winning over new customers.

A Japanese researcher may soon be developing rat and mouse embryos with human cells as part of a plan to eventually develop organs for transplants, according to Nature News.

The teams used different sequencing approaches — one using long reads and the other short reads — to uncover repeat expansions in people with a rare disease.

Maybe Not to Eat…

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.